Biostack Raises $9.5M Seed Led by Peak Xv

BioStack, a San Francisco-based healthcare technology company, has secured $9.5M in a Seed funding round led by Peak XV. This initial investment will help the company expand its operations within the United States and internationally, as well as develop its technology platform and enhance its engineering and research teams.

Other participants in this funding round include Afore Capital, DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures, and Y Combinator. The financial backing will focus on supporting BioStack's ambitious plan to connect fragmented clinical information across various healthcare systems.

BioStack is dedicated to constructing a comprehensive data infrastructure that integrates disjointed clinical information, which enables the creation of longitudinal patient records. These records incorporate notes, lab results, imaging, medications, treatment histories, and outcomes, allowing AI and biotech companies access to high-quality data necessary for model training that enhances understanding of disease progression and treatment effectiveness. The company is already working with a vast repository of over 100 million de-identified patient records globally, encompassing regions like the U.S., India, Brazil, and Argentina.

The platform powered by BioStack not only generates highly valuable datasets from de-identified information but also ensures patient privacy while establishing workflows tailored to individual provider protocols. This includes integrating biological and clinical data with treatment outcomes that support medical research and AI model training and evaluation.

Sanat Mishra serves as the CEO and co-founder of BioStack, leading the vision of the company to transform the way healthcare data is utilized, which is crucial for both clinicians’ decision-making processes and the future advancements in medical AI.

"Collecting every event linked to each patient enables a view of what happens at each stage of a patient's journey," Mishra noted, emphasizing the importance of creating a structured infrastructure that connects various clinical data points. This integrated approach can significantly influence personalized treatment strategies and medical breakthroughs moving forward.

Company	BioStack
Round	Seed
Amount	$9.5M
Lead Investor	Peak XV
Investors	Afore Capital, DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures, Y Combinator
Founders	Sanat Mishra
Sectors	Healthcare Technology